The integration of genomics into public health and medicine is happening at a faster rate than the accrual of the capabilities necessary to ensure the equitable, global distribution of its clinical benefits. These features of genomics indebt the genomics enterprise and compel the expanded scope of responsibility proposed by the authors of this special report.
⚡ This is an original paraphrased summary — not copied from the abstract. Full paper available at the source link below.
Understanding this could lead to better treatments, improved diagnostics, or a deeper grasp of how the human body works — benefiting patient care globally.
This summary is based on publicly available metadata and abstract. For the full research paper, visit the original source:
Read Full Paper at PubMed